Skip to main navigation
Logo

Investors

Press Releases

Press Releases

  • All
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2016
April 29, 2020
resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
January 9, 2020
Adicet Bio to Present at J.P. Morgan Healthcare Conference
October 2, 2019
Adicet Bio Raises $80M in Series B Financing
September 23, 2019
Adicet Bio Appoints Francesco Galimi, M.D., Ph.D., SVP and Chief Medical Officer
April 30, 2019
Adicet Bio Appoints Anil Singhal Chief Executive Officer
January 7, 2019
Adicet Bio to Present at J.P. Morgan Healthcare Conference on January 9
June 27, 2018
Adicet Bio appoints Stewart Abbot, Ph.D. as Chief Scientific Officer
March 6, 2018
Adicet Bio Announces the Transition of Founder, President and Chief Executive Officer Dr. Aya Jakobovits
September 19, 2016
Adicet Bio Named as One of FierceBiotech’s “Fierce 15” Biotech Companies of 2016
August 2, 2016
Regeneron and Adicet Bio Announce Strategic Collaboration to Discover and Develop Next Generation Engineered Immune Cell Therapeutics

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Next page next ›
  • Last page last »
Displaying 61 - 70 of 71

Tools

  • Print
    Print
  • Email Alerts
    Email Alerts
  • Investor Contacts
    Investor Contacts

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
  • Corporate Governance
  • Financial Information
  • Investor Resources

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
    • Stock Quote & Chart
    • Analyst Coverage
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts

Adicet - Header Navigation

  • About
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Gamma Delta T Cells
    • Targeting Moieties
    • Proprietary Cell Platform
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Presentations and Publications
  • Investors
    • Overview
    • Press Releases
    • Presentations & Events
    • Stock Information
    • Corporate Governance
    • Financial Information
    • Investor Resources
  • Careers
    • Join Our Team
    • Current Openings
  • Contact

IR Nav

  • Investors
  • Press Releases
  • Presentations & Events
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Governance Highlights
    • Leadership and Board of Directiors
  • Financial Information
  • Investor Resources
    • Investor FAQs
    • Information Request
    • Email Alerts
    • Investor Contacts
Logo © 2022 Adicet Bio All rights reserved. Website Design: Hane Chow, Inc.